Anti-infective
Antimalarial
ArteVita (Artemether & Lumefantrine) USP Tablets
Fixed-dose combination indicated for the treatment of acute uncomplicated Plasmodium falciparum malaria.
AntimalarialProduct overview
Fixed-dose combination indicated for the treatment of acute uncomplicated Plasmodium falciparum malaria.
- Composition
- Artemether 20/40/80 mg + Lumefantrine 120/240/480 mg
- Pack size
- 6 × 6 / 6 × 12 / 6 × 18 / 6 × 24 blister
- Category
- Antimalarial
- Dosage form
- Tablets & Capsules
Indications
- Acute uncomplicated P. falciparum malaria
- Travel-related antimalarial therapy
Key highlights
- WHO essential medicine
- Pediatric and adult strengths
- Heat-stable packaging for tropical climates
Manufactured under WHO-GMP & ISO 9001
Every batch is released against documented analytical and stability data. ACTD / CTD dossiers available for global registration.
Related products
Other molecules in Tablets & Capsules
Start a conversation
Tell us about your market — we'll respond in one working day.
From a single SKU enquiry to a full contract manufacturing partnership, our commercial team is ready with prices, dossier samples and lead times.